PT  - JOURNAL ARTICLE
AU  - O'Loughlin, Taryn
ED  - Mazzone, Theodore
TI  - Pioglitazone Exhibits a Beneficial Effect on CIMT in Patients with Type 2 Diabetes
DP  - 2006  01
TA  - MD Conference Express
PG  - 12--13
VI  - 6
IP  - 5
4099  - http://mdc.sagepub.com/content/6/5/12.short
4100  - http://mdc.sagepub.com/content/6/5/12.full
AB  - Patients with type 2 diabetes are at greater risk for cardiovascular events, and thiazolidinediones, approved for the management of type 2 diabetes, have demonstrated an atheroprotective effect in animal models of atheroscleroisis. The CHICAGO study sought to further elucidate the potential protective effect of the thiazolidinedione pioglitazone in patients with type 2 diabetes.